Mr. Vincent A. Forlenza, also known as Vince, serves as Chief Executive Officer and President of Becton, Dickinson U.K. Limited. Mr. Forlenza has been the Chairman of Becton, Dickinson and Company since July 1, 2012 and has been its Chief Executive Officer since October 1, 2011. He served as President of Becton, Dickinson and Company from January 1, 2009 to April 23, 2017. He joined Becton, Dickinson and Company in 1980 and served as its Chief Operating Officer from July 29, 2010 to October 1, 2011, Executive Vice President from June 2006 to January 1, 2009, President of BD Biosciences from March 14, 2003 to June 2006 and Senior Vice President of Technology, Strategy and Development. Mr. Forlenza held leadership positions of increasing responsibility in the United States and Europe. He was instrumental in the early development of two significant new infectious disease diagnostics systems, BD ProbeTec (TM) ET and BD Phoenix (TM). Mr. Forlenza is active in various professional and community associations. He serves as Chairman of the Advanced Medical Technology Association (AdvaMed) Board of Directors. He served as the Chairman of The Valley Hospital from 2006 to 2013. He served as the Chairman of AdvaMed Dx at Advanced Medical Technology Association since October 2010. As AdvaMed Dx Chairman, he oversaw significant growth of the division and helped establish AdvaMed Dx as the leading advocate for the value of diagnostics. Mr. Forlenza has been a Member of The Board of Trustees of The Valley Hospital at Valley Health System, Inc. since 2002. He has been a Director at Becton, Dickinson and Company since October 1, 2011. He serves on the Board of Trustees of Lehigh University. He served as a Member of the Advisory Council for the P.C. Rossin College of Engineering and Applied Sciences at Lehigh University. Mr. Forlenza obtained his BS in chemical engineering from Lehigh University in 1975 and his MBA from Wharton Graduate School, University of Pennsylvania in 1980.

 Business, Healthcare Instruments.